title: [The Washington summit: orange light for genome editing?].
abstract: The summit organised in early December 2015 considered in depth the various issues (technical, scientific, societal and ethical) raised by the prospect of genome editing using the extremely effective CRISPR system. Germline editing (for therapeutic or "enhancement" purposes) was stated to be irresponsible under current conditions, but the possibility that this could be considered in the future was not excluded; a mechanism for monitoring progress and possibly revising recommendations was proposed.
authors.affiliation: UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS, Espace éthique méditerranéen, hôpital d'adultes la Timone, 264, rue Saint-Pierre, 13385 Marseille Cedex 05, France - CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 09, France.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Jordan
mesh_terms: D001675:Bioethics; D024803:Biomedical Enhancement / Q000941:ethics; D064113:CRISPR-Cas Systems / Q000502:physiology; D003226:Congresses as Topic; D004219:District of Columbia; D000072669:Gene Editing / Q000941:ethics / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D015316:Genetic Therapy / Q000941:ethics / Q000331:legislation & jurisprudence / Q000523:psychology; D005854:Germ Cells / Q000378:metabolism; D006801:Humans; D017410:Practice Guidelines as Topic